Glenmark Pharmaceuticals
GLENMARK.NS
$16.71
Share price
-0.10%
Change (1 day)
34.01%
Change (1 year)
Categories
P/S ratio for Glenmark Pharmaceuticals (GLENMARK.NS)
P/S ratio as of April 2025 (TTM): 3.07
According to Glenmark Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.68. At the end of 2024 the company had a P/S ratio of 3.40.
P/S ratio history for Glenmark Pharmaceuticals from 2012 to 2024
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2024 | 3.40 | 69.38% |
| 2023 | 2.01 | 104.46% |
| 2022 | 0.9830 | -20.26% |
| 2021 | 1.23 | -6.98% |
| 2020 | 1.33 | 40.45% |
| 2019 | 0.9437 | -53.87% |
| 2018 | 2.05 | 10.39% |
| 2017 | 1.85 | -34.6% |
| 2016 | 2.83 | -21.58% |
| 2015 | 3.61 | 15.69% |
| 2014 | 3.12 | 26.2% |
| 2013 | 2.48 | -15.9% |
| 2012 | 2.94 |